Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

New research could aid development of cancer treatments
According to the authors, this discovery advances the understanding of mitochondrion-to-nucleus communication and intracellular signalling.

RVC-led study analyses cancer cells in humans and animals

A recent study that found a new interaction within cells has opened the door for new potential treatments of neurological conditions in humans and animals such as cancer and neurodegeneration.

The study was led by Professor Michelangelo Campanella, chair in Pharmacology and head of the Mitochondrial Cell Biology and Pharmacology Research Unit at the Royal Veterinary College (RVC).

Researchers analysed breast cancer cells of varying levels of aggressiveness from humans, dogs and cats. According to the study, the evolution of the breast cancer in these three species meant that their susceptibility to chemotherapy was found to be associated with the amount of contact sites between mitochondria and nuclei.

The study used multiple molecular pharmacology protocols to control the interaction between mitochondria and nuclei, as well as florescent imaging to map the interaction and transmission electron microscopy to picture the ultrastructure of Nucleus-Associated Mitochondria (NAM).

According to the authors, this discovery advances the understanding of mitochondrion-to-nucleus communication and intracellular signalling. Suggesting that this interaction inside cells can be targeted and controlled, allowing for new enhanced strategies for fighting diseases.

Professor Campanella said: “This study is the first of its kind to unveil the association between the mitochondrion and nucleus to be a regulated process and can be used to identify how this interplay can be pharmacologically controlled.

“The impact of this discovery is likely bigger than the advanced comprehension of mammalian cells physiology and pathology, embracing aspects of evolution. The co-existence of distinct DNAs is just partially understood and how genes from the mitochondria are transferred to genomic DNA is completely unknown.

“Our research group has now started investigating the molecular determinants of membrane tethering at NAM and the involvement of these inter-organellar communication in several disease models.

"This is truly ground-breaking as it will allow us to develop ways of correcting mitochondrial signalling in pathological conditions including cancer and neurodegeneration.”

Become a member or log in to add this story to your CPD history

Vets launch new podcast for pet owners

News Story 1
 Two independent vets have launched a podcast to help owners strengthen their bond with pets. Dr Maggie Roberts and Dr Vanessa Howie, who have worked in both veterinary practice and major charities, are keen to use their experience to enable people to give pets a better life.

The venture, called Vets Talking Pets, provides advice and information on a range of topics, including how to select a suitable pet, where to obtain them and how to get the best out of your vet. Maggie and Vanessa will also discuss sensitive subjects, including end-of-life care, raw food diets and the cost of veterinary care.

The podcast can be found on all the usual podcast sites, including Podbean, Apple, Amazon Music and YouTube. 

Click here for more...
News Shorts
VMD issues guidance on AVM-GSL packaging

The Veterinary Medicines Directorate (VMD) has shared advice on its requirements for medicines considered AVM-GSL.

The guidance explains the information that should be on the outer package, and sets out the typical maximum pack size for an AVM-GSL product. It also describes the user-friendly language, structure and phrases required on packaging and product leaflets.

AVM-GSL products do not require discussion between the purchaser and a veterinary professional. This means that clear product information is needed to support sales choices.

The information will be useful for submitting new products to the AVM-GSL category and lowering the distribution category of products from NFA-VPS to AVM-GSL.

The VMD's guidance can be accessed here.